ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,526,000 | +29.7% | 37,507 | +11.3% | 0.00% | +50.0% |
| Q3 2016 | $4,259,000 | +14.7% | 33,694 | +2.4% | 0.00% | 0.0% |
| Q2 2016 | $3,712,000 | +5.7% | 32,919 | -2.4% | 0.00% | 0.0% |
| Q1 2016 | $3,511,000 | -8.3% | 33,731 | -0.6% | 0.00% | 0.0% |
| Q4 2015 | $3,828,000 | -4.9% | 33,936 | -7.7% | 0.00% | 0.0% |
| Q3 2015 | $4,024,000 | +24.5% | 36,758 | +8.8% | 0.00% | 0.0% |
| Q2 2015 | $3,233,000 | +12.0% | 33,791 | +9.1% | 0.00% | 0.0% |
| Q1 2015 | $2,887,000 | +10.7% | 30,983 | -2.8% | 0.00% | +100.0% |
| Q4 2014 | $2,609,000 | -2.9% | 31,866 | -23.9% | 0.00% | -50.0% |
| Q3 2014 | $2,688,000 | +1.1% | 41,864 | -4.2% | 0.00% | 0.0% |
| Q2 2014 | $2,658,000 | +51.3% | 43,719 | +49.1% | 0.00% | +100.0% |
| Q1 2014 | $1,757,000 | -10.3% | 29,326 | -4.6% | 0.00% | 0.0% |
| Q4 2013 | $1,959,000 | -25.0% | 30,754 | -20.0% | 0.00% | -50.0% |
| Q3 2013 | $2,611,000 | +55.2% | 38,443 | +64.8% | 0.00% | +100.0% |
| Q2 2013 | $1,682,000 | – | 23,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |